Literature DB >> 20461429

Long survival and clinical stability in Marburg's variant multiple sclerosis.

Marco Turatti1, Alberto Gajofatto, Francesca Rossi, Marcella Vedovello, Maria Donata Benedetti.   

Abstract

Marburg's variant multiple sclerosis (MS) is an acute and aggressive atypical form of MS, leading frequently to death in few months. A 32-year-old man with motor and sensory symptoms suggestive of acute myelopathy, rapidly followed by cerebellar dysfunction and consciousness impairment. Clinical, laboratory and radiological evaluations suggested a central nervous system demyelinating disease. The diagnosis was Marburg's variant MS, usually leading to death in short time. He underwent different treatments, including steroids, cyclophosphamide, plasma exchange and lastly interferon-beta. The patient reached clinical stability with severe residual disability, persistent after 3 years from onset. This observation suggests that subjects with Marburg's MS might reach long clinical stability.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20461429     DOI: 10.1007/s10072-010-0287-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  8 in total

1.  Fulminant monophasic multiple sclerosis, Marburg's type.

Authors:  M D Johnson; P Lavin; W O Whetsell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-10       Impact factor: 10.154

2.  An autopsy case of acute multiple sclerosis (Marburg's type) during pregnancy.

Authors:  F Letournel; J Cassereau; C Scherer-Gagou; I Bernard; A Mercat; F Gray; J Y Tanguy; I Richard-Crémieux; Th Jeanfaivre; A Barthelaix; F Dubas
Journal:  Clin Neurol Neurosurg       Date:  2008-03-14       Impact factor: 1.876

3.  Four-year follow-up of a case of acute multiple sclerosis of the Marburg type.

Authors:  F Giubilei; A Sarrantonio; P Tisei; C Gasperini; M Salvetti
Journal:  Ital J Neurol Sci       Date:  1997-06

Review 4.  Consensus definitions proposed for pediatric multiple sclerosis and related disorders.

Authors:  Lauren B Krupp; Brenda Banwell; Silvia Tenembaum
Journal:  Neurology       Date:  2007-04-17       Impact factor: 9.910

5.  Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein.

Authors:  D D Wood; J M Bilbao; P O'Connors; M A Moscarello
Journal:  Ann Neurol       Date:  1996-07       Impact factor: 10.422

6.  Treatment of Marburg variant multiple sclerosis with mitoxantrone.

Authors:  Douglas R Jeffery; David S Lefkowitz; Jeffrey P Crittenden
Journal:  J Neuroimaging       Date:  2004-01       Impact factor: 2.486

7.  A case of rapid deterioration: acute multiple sclerosis of the Marburg type.

Authors:  J Jasperson; A G Jones
Journal:  J Neurosci Nurs       Date:  1998-12       Impact factor: 1.230

8.  Malignant monophasic multiple sclerosis or "Marburg's disease".

Authors:  M F Mendez; S Pogacar
Journal:  Neurology       Date:  1988-07       Impact factor: 9.910

  8 in total
  3 in total

1.  Fulminant demyelinating diseases.

Authors:  Megan R Rahmlow; Orhun Kantarci
Journal:  Neurohospitalist       Date:  2013-04

Review 2.  Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders.

Authors:  Meredith C Frederick; Michelle H Cameron
Journal:  Curr Neurol Neurosci Rep       Date:  2016-03       Impact factor: 5.081

3.  Recurrent Fulminant Tumefactive Demyelination With Marburg-Like Features and Atypical Presentation: Therapeutic Dilemmas and Review of Literature.

Authors:  Aigli G Vakrakou; Dimitrios Tzanetakos; Theodore Argyrakos; Georgios Koutsis; Maria-Eleptheria Evangelopoulos; Elisabeth Andreadou; Maria Anagnostouli; Marianthi Breza; John S Tzartos; Elias Gialafos; Antonios N Dimitrakopoulos; Georgios Velonakis; Panagiotis Toulas; Leonidas Stefanis; Constantinos Kilidireas
Journal:  Front Neurol       Date:  2020-06-30       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.